PULMONARY ARTERIAL HYPERTENSION
Clinical trials for PULMONARY ARTERIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
PAH drug study halted: LTP001 fails to show promise
Disease control TerminatedThis study tested an experimental drug called LTP001 in 47 people with pulmonary arterial hypertension (PAH), a condition where high blood pressure in the lungs makes it hard to breathe. The goal was to see if the drug could improve blood flow and exercise ability. The study was …
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:25 UTC
-
PAH drug study halted early – no patients completed full year
Disease control TerminatedThis study looked at the long-term safety of an experimental drug called LTP001 for people with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. It was an open-label extension, meaning everyone knew they were getting the drug. The stu…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New hope for PAH patients: sotatercept trial shows promise
Disease control TerminatedThis study tested a drug called sotatercept in people newly diagnosed with pulmonary arterial hypertension (PAH), a serious lung condition that makes it hard to breathe. The goal was to see if adding sotatercept to standard treatment could delay worsening of the disease. The tria…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE3 • Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Xenon MRI sheds light on hidden lung damage in hypertension patients
Knowledge-focused TerminatedThis study aimed to see if a special type of MRI, using xenon gas, could detect changes in the lungs of people with pulmonary hypertension (high blood pressure in the lungs). Researchers looked at how these MRI signals relate to disease severity and progression. The study involve…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION
Phase: PHASE2 • Sponsor: Bastiaan Driehuys • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC